Commission Delegated Directive (EU) 2026/2325

In forceThis text since 8 Nov 2026law://eu/dir/2026/2325/art_2__para_1@2026-11-10

Contents

1.Member States shall adopt and publish, by 31 January 2027 at the latest, the laws, regulations and administrative provisions necessary to comply with the Annex to this Directive referred to in Article 1. They shall forthwith communicate to the Commission the text of those provisions.They shall apply those provisions from 5 February 2027.When Member States adopt those provisions, they shall contain a reference to this Directive or be accompanied by such a reference on the occasion of their official publication. Member States shall determine how such reference is to be made.

Source: EUR-Lex, © European Union, 1998-2026. Reuse authorised under Decision 2011/833/EU.

Key facts

Type: Directive · Commission Delegated Directive (EU) 2026/2325
Adopted: 10 Jul 2026
In force: 8 Nov 2026
Made by: Directorate-General for Defence Industry and Space, European Commission
Official: EUR-Lex 32026L2325 · ELI

Topics

civil defence defence policy free movement of goods market approval military equipment public order Approximation of laws Industry Internal market - Principles Other Technology

History · 1 version

8 Nov 2026Reading

Connections

See on a map

Cites 1: this act

Defined terms · 11

Show every defined term

Anti-idiotypic antibodies
means antibodies which bind to the specific antigen binding sites of other antibodies;
Enzymes
means "biocatalysts" for specific chemical or biochemical reactions.
mixture
refers to a composition of two or more substances with at least one substance being listed in the ML8 sub-items.2.For the purposes of ML8, particle size is the mean particle diameter on a weight or volume basis.
modified
means any structural, electrical, mechanical, or other change that provides a non-military item with military capabilities equivalent to an item which is specially designed for military use.
Monoclonal antibodies
means proteins which bind to one antigenic site and are produced by a single clone of cells;
mountings
refers to weapon mounts or structural strengthening for the purposes of installing weapons.
non-magnetic
means the relative permeability is less than 2.
Polyclonal antibodies
means a mixture of proteins which bind to the specific antigen and are produced by more than one clone of cells;
production
includes design, examination, manufacture, testing and checking.
Receptors
means biological macromolecular structures capable of binding ligands, the binding of which affects physiological functions.
User-accessible programmability
refers to the facility allowing a user to insert, modify or replace "programs" by means other than: a.